$GSTX
Graphene & Solar Technologies Ltd

2022 Q1 Form 10-Q Financial Statement

#000157570522000546 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q3 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $442.1K $29.77M $3.585M
YoY Change -87.67% 16198.24% 2088.4%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $242.6K $102.3K $4.570K
YoY Change 5208.32% 2268.75% 15.99%
% of Gross Profit
Operating Expenses $442.1K $29.81M $3.585M
YoY Change -87.67% 16220.14% 2088.4%
Operating Profit
YoY Change
Interest Expense $4.835K -$22.11K $15.55K
YoY Change -68.91% 2005.71% -203.12%
% of Operating Profit
Other Income/Expense, Net $1.759K $4.540K -$13.23K
YoY Change -113.29% 111.16% -768.33%
Pretax Income -$440.3K -$29.82M -$3.598M
YoY Change -87.76% 14094.11% 1933.83%
Income Tax
% Of Pretax Income
Net Earnings -$440.3K -$29.82M -$3.598M
YoY Change -87.76% 14094.11% 1933.83%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.214K -$110.0K -$14.21K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q3 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.200K $3.730K $150.00
YoY Change 2700.0% 37200.0% -92.06%
Cash & Equivalents $4.196K $3.728K $147.00
Short-Term Investments
Other Short-Term Assets $19.27K $18.80K $15.72K
YoY Change 22.58% 31.66%
Inventory
Prepaid Expenses $19.27K $18.80K
Receivables
Other Receivables
Total Short-Term Assets $23.47K $22.53K $15.87K
YoY Change 47.88% 225150.0% -14.59%
LONG-TERM ASSETS
Property, Plant & Equipment $1.799K $2.250K $4.020K
YoY Change -55.25% -81.65% -77.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.292M $6.781M $4.020K
YoY Change 156423.08% 55207.09% -90.88%
TOTAL ASSETS
Total Short-Term Assets $23.47K $22.53K $15.87K
Total Long-Term Assets $6.292M $6.781M $4.020K
Total Assets $6.316M $6.803M $19.89K
YoY Change 31653.12% 55345.59% -68.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.359M $2.198M $785.4K
YoY Change 200.39% 236.34% 53.93%
Accrued Expenses $165.9K $154.4K $146.7K
YoY Change 13.09% 16.89% 29.02%
Deferred Revenue
YoY Change
Short-Term Debt $253.4K $239.4K $268.1K
YoY Change -5.46% 31.62% 56.15%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.970M $3.540M $2.010M
YoY Change 97.5% 110.12% 58.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.970M $3.540M $2.010M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.970M $3.540M $2.010M
YoY Change 97.5% 110.12% 58.29%
SHAREHOLDERS EQUITY
Retained Earnings -$59.34M -$46.05M
YoY Change
Common Stock $3.633K $3.437K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.345M $3.264M -$1.990M
YoY Change
Total Liabilities & Shareholders Equity $6.316M $6.803M $19.89K
YoY Change 31653.12% 55345.59% -68.25%

Cashflow Statement

Concept 2022 Q1 2021 Q3 2021 Q1
OPERATING ACTIVITIES
Net Income -$440.3K -$29.82M -$3.598M
YoY Change -87.76% 14094.11% 1933.83%
Depreciation, Depletion And Amortization $242.6K $102.3K $4.570K
YoY Change 5208.32% 2268.75% 15.99%
Cash From Operating Activities -$4.160K -$101.7K -$50.85K
YoY Change -91.82% -569.84% 83.31%
INVESTING ACTIVITIES
Capital Expenditures -$2.480K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.480K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -780.0 30.48K
YoY Change -100.0% -106.1% -2870.91%
NET CHANGE
Cash From Operating Activities -4.160K -101.7K -50.85K
Cash From Investing Activities -2.480K
Cash From Financing Activities 0.000 -780.0 30.48K
Net Change In Cash -4.160K -105.0K -20.37K
YoY Change -79.58% -404.82% -29.37%
FREE CASH FLOW
Cash From Operating Activities -$4.160K -$101.7K -$50.85K
Capital Expenditures -$2.480K
Free Cash Flow -$99.24K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001497649
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
usd
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
usd
gstx Issuance Of Short Term Note Payable
IssuanceOfShortTermNotePayable
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
gstx Debt Discount
DebtDiscount
usd
CY2021Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
usd
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
usd
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-174194
dei Entity Registrant Name
EntityRegistrantName
GRAPHENE & SOLAR TECHNOLOGIES LTD
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2888719
dei Entity Address Address Line1
EntityAddressAddressLine1
23 Corporate Plaza Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
dei Entity Address City Or Town
EntityAddressCityOrTown
Newport Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92660
dei City Area Code
CityAreaCode
(949)
dei Local Phone Number
LocalPhoneNumber
478-8387
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
88560 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1799 usd
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
362823733 shares
CY2022Q1 us-gaap Cash
Cash
4196 usd
CY2021Q3 us-gaap Cash
Cash
3728 usd
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
19272 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18797 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
23468 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
22525 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
88560 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2250 usd
CY2022Q1 gstx Intellectual Property At Cost Net Of Amortization
IntellectualPropertyAtCostNetOfAmortization
592385 usd
CY2021Q3 gstx Intellectual Property At Cost Net Of Amortization
IntellectualPropertyAtCostNetOfAmortization
592385 usd
CY2022Q1 gstx Intellectual Property At Cost
IntellectualPropertyAtCost
6287360 usd
CY2021Q3 gstx Intellectual Property At Cost
IntellectualPropertyAtCost
6777424 usd
CY2022Q1 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
975 usd
CY2021Q3 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
975 usd
CY2022Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2094 usd
CY2022Q1 us-gaap Assets
Assets
6315696 usd
CY2021Q3 us-gaap Assets
Assets
6803174 usd
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2359324 usd
CY2021Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2197894 usd
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
165897 usd
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
154412 usd
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1191781 usd
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
947826 usd
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
78705 usd
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
60000 usd
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
52703 usd
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
100747 usd
CY2022Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
168967 usd
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
173038 usd
CY2022Q1 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
5745 usd
CY2021Q3 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
6383 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3970419 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3539553 usd
CY2022Q1 us-gaap Liabilities
Liabilities
3970419 usd
CY2021Q3 us-gaap Liabilities
Liabilities
3539553 usd
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
362823733 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
362823733 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
246248723 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
246248723 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
3633 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
3437 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62427147 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49922922 usd
CY2022Q1 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
795000 usd
CY2021Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
720000 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59341703 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46050640 usd
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
51200 usd
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
107902 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2345277 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3263621 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6315696 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6803174 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
172282 usd
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
3545803 usd
us-gaap Professional Fees
ProfessionalFees
12726455 usd
us-gaap Professional Fees
ProfessionalFees
4130354 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
269782 usd
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38801 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
550456 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
81350 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
442064 usd
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
3584604 usd
us-gaap Operating Expenses
OperatingExpenses
13276911 usd
us-gaap Operating Expenses
OperatingExpenses
4211704 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
442064 usd
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3584604 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
13276911 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4211704 usd
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6594 usd
CY2021Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2318 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
11276 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4509 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
4835 usd
CY2021Q1 us-gaap Interest Expense
InterestExpense
15551 usd
us-gaap Interest Expense
InterestExpense
25428 usd
us-gaap Interest Expense
InterestExpense
29827 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1759 usd
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13233 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14152 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25318 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-440305 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3597837 usd
us-gaap Net Income Loss
NetIncomeLoss
-13291063 usd
us-gaap Net Income Loss
NetIncomeLoss
-4237022 usd
CY2022Q1 gstx Net Comprehensive Loss
NetComprehensiveLoss
-487761 usd
CY2021Q1 gstx Net Comprehensive Loss
NetComprehensiveLoss
-3582525 usd
gstx Net Comprehensive Loss
NetComprehensiveLoss
-13347765 usd
gstx Net Comprehensive Loss
NetComprehensiveLoss
-4304347 usd
CY2022Q1 gstx Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
CY2021Q1 gstx Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.01
gstx Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.04
gstx Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.02
CY2022Q1 gstx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
362823733 shares
CY2021Q1 gstx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
253168937 shares
gstx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
360019487 shares
gstx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
251406796 shares
CY2021Q3 us-gaap Shares Outstanding
SharesOutstanding
343237369 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3263621 usd
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
46921 usd
CY2021Q4 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
18386364 shares
CY2021Q4 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
12382500 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9246 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-12850758 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2833038 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-47456 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-440305 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2345277 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1672275 usd
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
84738 usd
CY2020Q4 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
405000 usd
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-82637 usd
CY2020Q4 us-gaap Profit Loss
ProfitLoss
-639185 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1904359 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30476 usd
CY2021Q1 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
43475 usd
CY2021Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
3422500 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15312 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-3597837 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1990433 usd
us-gaap Profit Loss
ProfitLoss
-13291063 usd
us-gaap Profit Loss
ProfitLoss
-4237022 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12382500 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3827500 usd
us-gaap Depreciation
Depreciation
521 usd
us-gaap Depreciation
Depreciation
8986 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
490064 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
13943 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
12582 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
142409 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
131957 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
11485 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
14603 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
2094 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
15723 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
203128 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
93041 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49107 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-164076 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
46921 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
115214 usd
gstx Issuance Of Short Term Note Payable
IssuanceOfShortTermNotePayable
115000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46921 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
230214 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2654 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-66003 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
468 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
135 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3728 usd
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4196 usd
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147 usd
gstx Debt Discount
DebtDiscount
43475 usd
us-gaap Long Term Debt Average Amount Outstanding
LongTermDebtAverageAmountOutstanding
70747 usd
gstx Net Income Losses
NetIncomeLosses
59705339 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zZcRye72uC2k" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86F_zDran0mU0B04">Use of Estimates</span> -</i> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"/>
CY2022Q1 us-gaap Cash
Cash
4196 usd
CY2021Q1 us-gaap Cash
Cash
147 usd
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2021Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
36710 usd
CY2020Q3 gstx Loan Amount
LoanAmount
5781 usd
us-gaap Long Term Debt Average Amount Outstanding
LongTermDebtAverageAmountOutstanding
70747 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
12382500 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
405000 usd
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
9485000 usd
CY2022Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
13500000 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zqTEUEcM2g6l" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_z5RqGyGJTu8"><i>Reclassifications </i></span>- Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported. </p> <p id="xdx_865_zRolX115wylg" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"/>
CY2022Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
168967 usd
CY2021Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
168967 usd
CY2022Q1 us-gaap Notes Payable
NotesPayable
78705 usd
CY2021Q3 us-gaap Notes Payable
NotesPayable
60000 usd
CY2022Q1 us-gaap Other Loans Payable
OtherLoansPayable
5745 usd
CY2021Q3 us-gaap Other Loans Payable
OtherLoansPayable
5623 usd
CY2022Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
99701 usd
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
96710 usd
CY2022Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
39701 usd
CY2022Q1 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
1191781 usd
CY2021Q3 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
947826 usd
us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
1200000 shares
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
46921 usd
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
5778366 shares
CY2022Q1 us-gaap Litigation Reserve
LitigationReserve
0 usd
CY2022Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
6879745 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-592385 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6287360 usd

Files In Submission

Name View Source Status
0001575705-22-000546-index-headers.html Edgar Link pending
0001575705-22-000546-index.html Edgar Link pending
0001575705-22-000546.txt Edgar Link pending
0001575705-22-000546-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gstx-20220331.xsd Edgar Link pending
gstx-20220331_cal.xml Edgar Link unprocessable
gstx-20220331_def.xml Edgar Link unprocessable
gstx-20220331_lab.xml Edgar Link unprocessable
gstx-20220331_pre.xml Edgar Link unprocessable
gstx_2q22.htm Edgar Link pending
gstx_2q22_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending